Profile data is unavailable for this security.
Mergers & acquisitions
| Acquired company | QTTB:NMQ since announced | Transaction value |
|---|---|---|
| Q32 Bio Inc | 85.61% | -- |
Data delayed at least 15 minutes, as of May 23 2024 21:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nautilus Biotechnology Inc | 0.00 | -67.44m | 346.98m | 163.00 | -- | 1.39 | -- | -- | -0.5402 | -0.5402 | 0.00 | 1.99 | 0.00 | -- | -- | 0.00 | -21.26 | -- | -21.85 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -9.93 | -- | -- | -- |
| Tenaya Therapeutics Inc | 0.00 | -124.58m | 347.05m | 140.00 | -- | 2.19 | -- | -- | -1.65 | -1.65 | 0.00 | 2.01 | 0.00 | -- | -- | 0.00 | -57.91 | -- | -63.59 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -0.3388 | -- | -- | -- |
| Precigen Inc | 5.44m | -96.91m | 348.34m | 202.00 | -- | 3.56 | -- | 64.04 | -0.3896 | -0.3896 | 0.0219 | 0.3877 | 0.0289 | -- | 4.12 | 26,925.74 | -51.49 | -31.50 | -64.42 | -38.63 | -4.19 | 44.00 | -1,781.73 | -232.32 | -- | -- | 0.00 | -- | -76.87 | -47.16 | -20.22 | -- | -48.30 | -- |
| Sutro Biopharma Inc | 154.07m | -114.96m | 348.44m | 300.00 | -- | 2.71 | -- | 2.26 | -1.89 | -1.89 | 2.53 | 1.57 | 0.4047 | -- | 7.48 | 510,149.00 | -30.20 | -25.48 | -36.94 | -29.75 | -- | -- | -74.62 | -113.71 | -- | -- | 0.00 | -- | 126.84 | 31.96 | 10.41 | -- | 22.61 | -- |
| Tourmaline Bio Inc | 0.00 | -32.94m | 349.56m | 44.00 | -- | 0.9871 | -- | -- | -5.35 | -5.35 | 0.00 | 13.81 | 0.00 | -- | -- | 0.00 | -12.39 | -- | -12.75 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 42.99 | -- | -- | -- |
| Zura Bio Ltd | 0.00 | -60.18m | 351.53m | 14.00 | -- | 3.94 | -- | -- | -1.63 | -1.63 | 0.00 | 1.40 | 0.00 | -- | -- | 0.00 | -86.77 | -- | -127.21 | -- | -- | -- | -- | -- | -- | -- | 0.021 | -- | -- | -- | -2,050.99 | -- | -- | -- |
| Fibrobiologics Inc | 0.00 | -22.53m | 351.73m | 10.00 | -- | -- | -- | -- | -1.03 | -1.03 | 0.00 | -0.1181 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -272.15 | -- | -- | -- |
| ADC Therapeutics SA | 68.62m | -227.23m | 353.01m | 273.00 | -- | -- | -- | 5.14 | -2.77 | -2.77 | 0.8368 | -2.35 | 0.1769 | 0.2683 | 2.91 | 251,351.60 | -56.99 | -48.41 | -69.99 | -55.63 | 93.30 | -- | -322.09 | -308.62 | 4.35 | -4.14 | 1.85 | -- | -66.86 | 127.56 | -52.78 | -- | 5.42 | -- |
| Aura Biosciences Inc | 0.00 | -78.65m | 354.73m | 88.00 | -- | 1.70 | -- | -- | -1.86 | -1.86 | 0.00 | 4.22 | 0.00 | -- | -- | 0.00 | -35.66 | -- | -37.16 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -30.03 | -- | -- | -- |
| Q32 Bio Inc | 354.00k | -83.09m | 355.40m | 39.00 | -- | 7.28 | -- | 1,003.95 | -25.73 | -25.73 | 0.1182 | 4.09 | 0.002 | -- | -- | 50,571.43 | -34.17 | -34.98 | -40.05 | -37.92 | -- | -- | -16,901.98 | -971.76 | -- | -- | 0.2039 | -- | -63.97 | -26.32 | -2,156.96 | -- | -60.90 | -- |
| Cerus Corp | 191.72m | -31.56m | 356.84m | 288.00 | -- | 7.22 | -- | 1.86 | -0.1742 | -0.1742 | 1.06 | 0.2671 | 0.9623 | 1.92 | 8.03 | 665,680.60 | -15.91 | -25.99 | -24.20 | -40.62 | 61.73 | 61.90 | -16.53 | -35.81 | 1.72 | -2.16 | 0.6287 | -- | -0.8061 | 19.69 | 12.37 | -- | 32.07 | -- |
| Amarin Corporation plc (ADR) | 277.46m | -52.61m | 358.20m | 275.00 | -- | 0.6559 | -- | 1.29 | -0.1288 | -0.1288 | 0.679 | 1.33 | 0.3363 | 0.4197 | 2.23 | 1,008,927.00 | -6.38 | -4.48 | -8.90 | -6.54 | 63.61 | 75.70 | -18.96 | -8.59 | 1.93 | -- | 0.00 | -- | -16.87 | 6.01 | 44.13 | -- | 55.83 | -- |
| Jasper Therapeutics Inc | 0.00 | -63.93m | 359.34m | 45.00 | -- | 3.17 | -- | -- | -5.60 | -5.60 | 0.00 | 7.51 | 0.00 | -- | -- | 0.00 | -48.30 | -- | -51.58 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -71.06 | -- | -- | -- |
| Shattuck Labs Inc | 2.72m | -85.08m | 362.81m | 75.00 | -- | 2.81 | -- | 133.63 | -1.93 | -1.93 | 0.0608 | 2.71 | 0.0168 | -- | -- | 36,200.00 | -52.52 | -29.14 | -57.94 | -32.42 | -- | -- | -3,133.63 | -565.33 | -- | -- | 0.00 | -- | 154.14 | -40.62 | 14.37 | -- | -19.15 | -- |
| MeiraGTx Holdings PLC | 11.38m | -74.11m | 363.98m | 402.00 | -- | 2.99 | -- | 31.98 | -1.27 | -1.27 | 0.1887 | 1.89 | 0.0381 | -- | 0.4821 | 27,159.90 | -24.81 | -26.40 | -31.62 | -32.66 | -- | -- | -651.19 | -420.70 | -- | -27.54 | 0.3729 | -- | -11.95 | -- | 35.17 | -- | 12.37 | -- |
| Replimune Group Inc | 0.00 | -215.79m | 364.03m | 331.00 | -- | 0.9725 | -- | -- | -3.24 | -3.24 | 0.00 | 6.10 | 0.00 | -- | -- | 0.00 | -38.05 | -29.08 | -40.71 | -30.56 | -- | -- | -- | -- | -- | -- | 0.1593 | -- | -- | -- | -23.82 | -- | 16.84 | -- |
Data as of May 23 2024. Currency figures normalised to Q32 Bio Inc's reporting currency: US Dollar USD
7.76%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Temasek Holdings Pte Ltd. (Investment Management)as of 31 Mar 2024 | 313.94k | 2.63% |
| Adar1 Capital Management LLCas of 31 Mar 2024 | 187.57k | 1.57% |
| Platinum Investment Management Ltd.as of 31 Mar 2024 | 109.96k | 0.92% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 106.75k | 0.90% |
| Exome Asset Management LLCas of 31 Mar 2024 | 65.02k | 0.55% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 41.30k | 0.35% |
| Affinity Asset Advisors LLCas of 31 Mar 2024 | 27.78k | 0.23% |
| Ensign Peak Advisors, Inc.as of 31 Mar 2024 | 25.73k | 0.22% |
| BML Capital Management LLCas of 31 Mar 2024 | 24.89k | 0.21% |
| Ikarian Capital LLCas of 31 Mar 2024 | 22.34k | 0.19% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
